Design and Biological Evaluation of hBest1-Containing Bilayer Nanostructures

Area of Science:

• Biochemistry
• Cell Biology
• Ophthalmology

Background:

• Bestrophinopathies are inherited retinal diseases linked to mutations in the BEST1 gene.
• The BEST1 gene encodes bestrophin-1 (hBest1), a calcium-dependent channel in retinal pigment epithelial (RPE) cells.
• Previous studies explored hBest1's behavior in model membranes, influencing its structure-function relationship.

Purpose of the Study:

• To integrate pure hBest1 protein into novel lipid bilayer nanostructures.
• To assess the cytotoxicity and cellular incorporation of these hBest1-containing nanostructures.
• To explore a potential therapeutic strategy for RPE cells affected by mutated hBest1.

Main Methods:

• Synthesis and characterization of hBest1-integrated nanostructures using DPPC, SM, GMO, and cholesterol.
• Cytotoxicity assays to evaluate nanoparticle safety.
• Immunofluorescence staining to determine incorporation into cell membranes and/or cells using MDCK II as a model system.

Main Results:

• Newly designed nanoparticles containing hBest1 were found to be non-cytotoxic.
• Successful incorporation of these nanostructures into MDCK II cell membranes was observed.
• These findings suggest a potential mechanism for restoring ion transport functions in RPE cells.

Conclusions:

• hBest1-containing nanostructures offer a promising, non-toxic approach for therapeutic intervention.
• Cellular incorporation into model membranes indicates potential application for inherited retinal diseases.
• This strategy may restore ion channel function in RPE cells with mutated hBest1, addressing bestrophinopathies.